Clinical Trial Update: Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating micafungin in combination with liposomal amphotericin B for aspergillosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Aspergillosis | Phase 2 | Status: TERMINATED